Author Index
Search or browse for an author across our entire electronic archive
Search results for: Y
Results 61 - 70 of 434 shown below
Yamana, K
T Itoi, K Yamana, V Bilim, K Takahashi and F Tomita
Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients
doi:10.1038/sj.bjc.6601454
Abstract | Full article | PDF
-
K Yamana, V Bilim, N Hara, T Kasahara, T Itoi, R Maruyama, T Nishiyama, K Takahashi and Y Tomita
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
advance online publication, 2005-08-09 00:00:00.000;
doi:10.1038/sj.bjc.6602732
Abstract | Full article | PDF
-
R Maruyama, K Yamana, T Itoi, N Hara, V Bilim, T Nishiyama, K Takahashi and Y Tomita
Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
advance online publication, 2006-10-10 00:00:00.000;
doi:10.1038/sj.bjc.6603359
Abstract | Full article | PDF
Yamanaka, H
H Nakazato, K Suzuki, H Matsui, N Ohtake, S Nakata and H Yamanaka
Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population
doi:10.1038/sj.bjc.6601075
Abstract | Full article | PDF
-
H Koike, K Ito, Y Takezawa, T Oyama, H Yamanaka and K Suzuki
Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer
doi:10.1038/sj.bjc.6602520
Abstract | Full article | PDF
Yamanaka, K
M Kumano, H Miyake, T Kurahashi, K Yamanaka and M Fujisawa
Enhanced progression of human prostate cancer PC3 cells induced by the microenvironment of the seminal vesicle
advance online publication, 2008-01-08 00:00:00.000;
doi:10.1038/sj.bjc.6604169
Abstract | Full article | PDF
-
H Miyake, I Hara, K Yamanaka, K Gohji, S Arakawa and S Kamidono
Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells
doi:10.1038/sj.bjc.6690264
Yamanaka, R
R Yamanaka, T Abe, N Yajima, N Tsuchiya, J Homma, T Kobayashi, M Narita, M Takahashi and R Tanaka
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
doi:10.1038/sj.bjc.6601268
Abstract | Full article | PDF
Yamanaka, T
T Yamanaka, S Matsumoto, S Teramukai, R Ishiwata, Y Nagai and M Fukushima
Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma
advance online publication, 2007-06-05 00:00:00.000;
doi:10.1038/sj.bjc.6603831
Abstract | Full article | PDF
Yamanaka, Y
K Yonemori, M Ando, M Yunokawa, T Hirata, T Kouno, C Shimizu, K Tamura, N Katsumata, A Hirakawa, K Matsumoto, Y Yamanaka, H Arioka and Y Fujiwara
Irinotecan plus carboplatin for patients with carcinoma of unknown primary site
advance online publication, 2008-12-16 00:00:00.000;
doi:10.1038/sj.bjc.6604829
Abstract | Full article | PDF
Yamanda, T
S Sone, F Li, Z-G Yang, T Honda, Y Maruyama, S Takashima, M Hasegawa, S Kawakami, K Kubo, M Haniuda and T Yamanda
Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner
doi:10.1054/bjoc.2000.1531
Yamano, T
K Kariyama, T Higashi, Y Kobayashi, K Nouso, H Nakatsukasa, T Yamano, M Ishizaki, T Kaneyoshi, N Toshikuni, T Ohnishi, K Fujiwara, E Nakayama, L Terracciano, G C Spagnoli and T Tsuji
Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma
doi:10.1038/sj.bjc.6690810
Yamano, Y
H Nomura, K Uzawa, Y Yamano, K Fushimi, T Ishigami, Y Kato, K Saito, D Nakashima, M Higo, Y Kouzu, K Ono, K Ogawara, M Shiiba, H Bukawa, H Yokoe and H Tanzawa
Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis
advance online publication, 2007-08-28 00:00:00.000;
doi:10.1038/sj.bjc.6603948
Abstract | Full article | PDF
Yamaoka, H
E Hiyama, H Yamaoka, T Matsunaga, Y Hayashi, H Ando, S Suita, H Horie, M Kaneko, F Sasaki, K Hashizume, A Nakagawara, N Ohnuma and T Yokoyama
High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma
advance online publication, 2004-07-27 00:00:00.000;
doi:10.1038/sj.bjc.6602054
Abstract | Full article | PDF
-
S Honda, Y Arai, M Haruta, F Sasaki, M Ohira, H Yamaoka, H Horie, A Nakagawara, E Hiyama, S Todo and Y Kaneko
Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma
advance online publication, 2008-10-28 00:00:00.000;
doi:10.1038/sj.bjc.6604754
Abstract | Full article | PDF
